Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04018677
Other study ID # IRB-44783
Secondary ID VAR0182IRB-44783
Status Completed
Phase N/A
First received
Last updated
Start date May 7, 2019
Est. completion date June 25, 2022

Study information

Verified date August 2023
Source Stanford University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this project is to iteratively develop and test a TOGETHER pilot mobile app product in preparation for commercialization. TOGETHER is a mobile application on a smart software system that informal caregivers can use to develop and implement home-based care for cancer patients/survivors. The Technical Objectives are to: 1. Establish the project team and obtain stakeholder feedback on what to include in the product. 2. Evaluate IT customization requirements and HIPAA compliance security, and privacy protocols. 3. Develop a prototype to show NCI and then a pilot version for beta and usability testing among stakeholders. 4. Enhance interoperability and test integration into health system(s) - if feasible. 5. Develop user support documentation for stakeholders.


Recruitment information / eligibility

Status Completed
Enrollment 14
Est. completion date June 25, 2022
Est. primary completion date July 21, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adults (aged 18 years or older) who are either: - Cancer patient/survivor receiving care or with plans to transition to care in the community setting. - Caregiver of cancer patient/survivor receiving care or with plans to transition to care in the community setting. - Clinician of cancer patient/survivor receiving care or with plans to transition to care in the community setting. - Cancer patient is a patient of Stanford Health Care. - Patient, Caregiver, and Clinician are willing to be connected on the app. - Have a smartphone and data plan that allows for app installation and usage. - Must speak, read and write in English, because all study materials and communication will be in English. Exclusion Criteria: - Patient does not have a cancer diagnosis. - Cancer patient/survivor is not receiving care or does not have plans to transition to care in the community setting. - Cancer patient is not a patient of Stanford Health Care. - Patient, Caregiver, and Clinician are not willing to be connected on the app. - Unable to speak, read and write in English. - Does not have a smartphone nor data plan that allows for app installation and usage

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Use of TOGETHERCare app
TOGETHERCare (Medable Inc.) is a mobile software application on a smart software system that informal caregivers can use to develop and implement home-based care for cancer patients/survivors. It is intended to improve the care experience by helping to alleviate the cancer care-giving burden and facilitate communication with patients' healthcare teams by centering the conversation around a care plan.

Locations

Country Name City State
United States Stanford University Stanford California

Sponsors (3)

Lead Sponsor Collaborator
Stanford University Medable Inc., National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

References & Publications (1)

Oakley-Girvan I, Davis SW, Kurian A, Rosas LG, Daniels J, Palesh OG, Mesia RJ, Kamal AH, Longmire M, Divi V. Development of a Mobile Health App (TOGETHERCare) to Reduce Cancer Care Partner Burden: Product Design Study. JMIR Form Res. 2021 Aug 13;5(8):e226 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Assess user experience with TOGETHER app User experiences will be assessed by measuring overall experiences. 1 year
Primary Assess user experience with TOGETHER app User experiences will be assessed by measuring module recommendation. 1 year
Primary Assess user experience with TOGETHER app User experiences will be assessed by measuring dynamics/flow of app use, module recommendation, and general demographics. 1 year
Primary Assess user experience with TOGETHER app User experiences will be assessed by measuring problems with app use. 1 year
Primary Assess caregiver's experience with TOGETHER app Caregiver's experience with TOGETHER app will be assessed for clarity of documentation. 1 year
Primary User documentation feedback General feedback/recommendations for the app, including user documentation feedback. 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients